Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NASDAQ:PBYI)

124.15
Delayed Data
As of Oct 16
 -0.20 / -0.16%
Today’s Change
28.35
Today|||52-Week Range
127.02
+304.40%
Year-to-Date
No recent news for Puma Biotechnology Inc.

Today’s Trading

Previous close124.35
Today’s open124.20
Day’s range123.75 - 126.65
Volume474,582
Average volume (3 months)870,696
Market cap$4.6B
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-11.28%
Earnings growth (this year)-4.76%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book21.82

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.05-0.72%
PTLAPortola Pharmaceutic...-0.55-1.07%
CLVSClovis Oncology Inc+0.31+0.37%
MNKMallinckrodt Plc-1.01-3.03%
Data as of 10/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$2.49
Annual revenue (last year)$0.00
Annual profit (last year)-$276.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts